Jim Polewaczyk

Track

Insider profile

Currently holds a position at IDEXX Laboratories Inc

Performance

Overall performance
2.7
Performance over holding periods
2.7
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 49% 68% 82%
Transactions
24 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Executive Vice President and Chief Commercial Officer IDEXX Laboratories Inc Jan. 1, 2020 -
Corporate Vice President - CAG Reference Laboratories and Telemedicine Line of Business IDEXX Laboratories Inc July 1, 2012 - Dec. 1, 2013
Corporate Vice President - Rapid Assay and Digital Imaging and Telemedicine Lines of Business IDEXX Laboratories Inc Feb. 5, 2007 - July 1, 2012
Jim Polewaczyk's trades of IDEXX Laboratories Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
575.07
Quantity 8,104
Value US$4,660,367
Transaction date
Proposed sale
Price
482.60
Quantity 11,636
Value US$5,615,534
Transaction date
Proposed sale
Price
508.00
Quantity 22,909
Value US$11,637,772
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-03-07 2024-03-06
S Sale
64,721 +40.1%
446.41
US$2,261,166 		64,721 +40.1% 446.41 US$2,261,166
2024-03-07 2024-03-06
S Sale
89,054 +34.6%
461.32
US$190,581 		89,054 +34.6% 461.32 US$190,581
2024-03-07 2024-03-06
S Sale
14,097 -10.9%
240.24
US$4,530,670 		14,097 -10.9% 240.24 US$4,530,670
2024-03-06 2024-03-06
PrS Proposed sale
8,104
575.07
US$4,660,367 		8,104 575.07 US$4,660,367
2023-12-08 2023-12-07
S Sale
3,940 -28.2%
523.56
US$2,062,812 		3,940 -28.2% 523.56 US$2,062,812
2023-12-08 2023-12-07
S Sale
1,202 -7.9%
522.31
US$627,816 		1,202 -7.9% 522.31 US$627,816
2023-12-08 2023-12-07
S Sale
3,378 -18.2%
521.00
US$1,759,954 		3,378 -18.2% 521.00 US$1,759,954
2023-12-08 2023-12-07
S Sale
3,116 -14.4%
520.19
US$1,620,919 		3,116 -14.4% 520.19 US$1,620,919
2023-12-07 2023-12-07
PrS Proposed sale
11,636
482.60
US$5,615,534 		11,636 482.60 US$5,615,534
2023-08-31 2023-08-29
S Sale
2,887 -22.3%
511.22
US$1,475,903 		2,887 -22.3% 511.22 US$1,475,903
2023-08-31 2023-08-29
S Sale
7,473 -36.6%
511.03
US$3,818,917 		7,473 -36.6% 511.03 US$3,818,917
2023-08-31 2023-08-29
S Sale
3,318 -14.0%
510.47
US$1,693,728 		3,318 -14.0% 510.47 US$1,693,728
2023-08-31 2023-08-29
S Sale
6,186 -20.7%
510.38
US$3,157,196 		6,186 -20.7% 510.38 US$3,157,196
2023-08-31 2023-08-29
S Sale
2,545 -7.8%
509.32
US$1,296,221 		2,545 -7.8% 509.32 US$1,296,221
2023-08-31 2023-08-29
S Sale
500 -1.5%
508.96
US$254,482 		500 -1.5% 508.96 US$254,482
2023-08-29 2023-08-29
PrS Proposed sale
22,909
508.00
US$11,637,772 		22,909 508.00 US$11,637,772
2021-12-01 2021-11-29
PlS Planned sale
4,595 -23.7%
633.00
US$2,908,635 		4,595 -23.7% 633.00 US$2,908,635
2021-06-01 2021-05-28
S Sale
200 -1.0%
565.56
US$113,111 		200 -1.0% 565.56 US$113,111
2021-06-01 2021-05-28
S Sale
513 -2.5%
564.73
US$289,704 		513 -2.5% 564.73 US$289,704
2021-06-01 2021-05-28
S Sale
1,713 -7.7%
564.04
US$966,198 		1,713 -7.7% 564.04 US$966,198
2021-06-01 2021-05-28
S Sale
2,462 -9.9%
562.65
US$1,385,253 		2,462 -9.9% 562.65 US$1,385,253
2021-06-01 2021-05-28
S Sale
1,429 -5.4%
561.77
US$802,771 		1,429 -5.4% 561.77 US$802,771
2021-06-01 2021-05-28
S Sale
1,274 -4.6%
560.79
US$714,451 		1,274 -4.6% 560.79 US$714,451
2021-06-01 2021-05-28
S Sale
1,370 -4.7%
559.77
US$766,879 		1,370 -4.7% 559.77 US$766,879
2021-06-01 2021-05-28
S Sale
1,039 -3.5%
558.89
US$580,690 		1,039 -3.5% 558.89 US$580,690
2020-05-12 2020-05-11
S Sale
4,028 -18.5%
299.29
US$1,205,559 		4,028 -18.5% 299.29 US$1,205,559
2020-05-12 2020-05-11
S Sale
11,110 -38.5%
298.75
US$3,319,088 		11,110 -38.5% 298.75 US$3,319,088
2020-05-12 2020-05-11
S Sale
1,126 -6.0%
298.28
US$335,869 		1,126 -6.0% 298.28 US$335,869